| GABAB-receptor subtypes assemble into functional heteromeric complexes K Kaupmann, B Malitschek, V Schuler, J Heid, W Froestl, P Beck, ... Nature 396 (6712), 683-687, 1998 | 1482 | 1998 |
| Expression cloning of GABAB receptors uncovers similarity to metabotropic glutamate receptors K Kaupmann, K Huggel, J Heid, PJ Flor, S Bischoff, SJ Mickel, ... Nature 386 (6622), 239-246, 1997 | 1278 | 1997 |
| Molecular Structure and Physiological Functions of GABAB Receptors B Bettler, K Kaupmann, J Mosbacher, M Gassmann Physiological reviews 84 (3), 835-867, 2004 | 1184 | 2004 |
| International Union of Pharmacology. XXXIII. Mammalian γ-aminobutyric acidB receptors: structure and function NG Bowery, B Bettler, W Froestl, JP Gallagher, F Marshall, M Raiteri, ... Pharmacological reviews 54 (2), 247-264, 2002 | 825 | 2002 |
| Cloning of a cDNA for a glutamate receptor subunit activated by kainate but not AMPA J Egebjerg, B Bettler, I Hermans-Borgmeyer, S Heinemann Nature 351 (6329), 745-748, 1991 | 799 | 1991 |
| The Concise Guide to PHARMACOLOGY 2019/20: G protein‐coupled receptors SPH Alexander, A Christopoulos, AP Davenport, E Kelly, A Mathie, ... British journal of pharmacology 176, S21-S141, 2019 | 793 | 2019 |
| Cloning of a novel glutamate receptor subunit, GluR5: expression in the nervous system during development B Bettler, J Boulter, I Hermans-Borgmeyer, A O'Shea-Greenfield, ... Neuron 5 (5), 583-595, 1990 | 792 | 1990 |
| AMPA and kainate receptors B Bettler, C Mulle Neuropharmacology 34 (2), 123-139, 1995 | 665 | 1995 |
| Epilepsy, hyperalgesia, impaired memory, and loss of pre-and postsynaptic GABAB responses in mice lacking GABAB (1) V Schuler, C Lüscher, C Blanchet, N Klix, G Sansig, K Klebs, M Schmutz, ... Neuron 31 (1), 47-58, 2001 | 653 | 2001 |
| Agonist selectivity of glutamate receptors is specified by two domains structurally related to bacterial amino acid-binding proteins Y Stern-Bach, B Bettler, M Hartley, PO Sheppard, PJ O'Hara, ... Neuron 13 (6), 1345-1357, 1994 | 593 | 1994 |
| Altered synaptic physiology and reduced susceptibility to kainate-induced seizures in GluR6-deficient mice C Mulle, A Sailer, I Pérez-Otaño, H Dickinson-Anson, PE Castillo, ... Nature 392 (6676), 601-605, 1998 | 581 | 1998 |
| The Concise Guide to PHARMACOLOGY 2021/22: G protein‐coupled receptors SPH Alexander, A Christopoulos, AP Davenport, E Kelly, A Mathie, ... British journal of pharmacology 178, S27-S156, 2021 | 494 | 2021 |
| Allosteric interactions between GB1 and GB2 subunits are required for optimal GABAB receptor function T Galvez, B Duthey, J Kniazeff, J Blahos, G Rovelli, B Bettler, L Prézeau, ... The EMBO journal, 2001 | 468 | 2001 |
| GABAB receptors–the first 7TM heterodimers FH Marshall, KA Jones, K Kaupmann, B Bettler Trends in pharmacological sciences 20 (10), 396-399, 1999 | 462 | 1999 |
| Cloning of a putative glutamate receptor: a low affinity kainate-binding subunit B Bettler, J Egebjerg, G Sharma, G Pecht, I Hermans-Borgmeyer, C Moll, ... Neuron 8 (2), 257-265, 1992 | 461 | 1992 |
| Regulation of neuronal GABAB receptor functions by subunit composition M Gassmann, B Bettler Nature Reviews Neuroscience 13 (6), 380-394, 2012 | 394 | 2012 |
| Differential compartmentalization and distinct functions of GABAB receptor variants R Vigot, S Barbieri, H Bräuner-Osborne, R Turecek, R Shigemoto, ... Neuron 50 (4), 589-601, 2006 | 383 | 2006 |
| C-terminal interaction is essential for surface trafficking but not for heteromeric assembly of GABAB receptors A Pagano, G Rovelli, J Mosbacher, T Lohmann, B Duthey, D Stauffer, ... Journal of Neuroscience 21 (4), 1189-1202, 2001 | 376 | 2001 |
| TAAR1 activation modulates monoaminergic neurotransmission, preventing hyperdopaminergic and hypoglutamatergic activity FG Revel, JL Moreau, RR Gainetdinov, A Bradaia, TD Sotnikova, R Mory, ... Proceedings of the national academy of sciences 108 (20), 8485-8490, 2011 | 370 | 2011 |
| Trace amine-associated receptor 1 modulates dopaminergic activity L Lindemann, CA Meyer, K Jeanneau, A Bradaia, L Ozmen, ... Journal of Pharmacology and Experimental Therapeutics 324 (3), 948-956, 2008 | 360 | 2008 |
Wolfgang FroestlAC Immune SA, Lausanne, SwitzerlandVerified email at acimmune.com
